LIFE.B Stock Overview
Evolve Global Healthcare Enhanced Yield Fund is an exchange traded fund launched and managed by Evolve Funds Group Inc.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Evolve Global Healthcare Enhanced Yield Fund Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$24.33 |
52 Week High | CA$25.92 |
52 Week Low | CA$22.79 |
Beta | 0 |
1 Month Change | -4.10% |
3 Month Change | -2.49% |
1 Year Change | -6.13% |
3 Year Change | 4.11% |
5 Year Change | 16.41% |
Change since IPO | 23.88% |
Recent News & Updates
Recent updates
Shareholder Returns
LIFE.B | CA Capital Markets | CA Market | |
---|---|---|---|
7D | -1.7% | 1.5% | 1.2% |
1Y | -6.1% | 26.2% | 6.1% |
Return vs Industry: LIFE.B underperformed the Canadian Capital Markets industry which returned 18.5% over the past year.
Return vs Market: LIFE.B underperformed the Canadian Market which returned 3.9% over the past year.
Price Volatility
LIFE.B volatility | |
---|---|
LIFE.B Average Weekly Movement | 1.1% |
Capital Markets Industry Average Movement | 4.2% |
Market Average Movement | 9.1% |
10% most volatile stocks in CA Market | 18.1% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: LIFE.B has not had significant price volatility in the past 3 months.
Volatility Over Time: LIFE.B's weekly volatility (1%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | n/a | n/a | evolveetfs.com/product/life/ |
Evolve Global Healthcare Enhanced Yield Fund is an exchange traded fund launched and managed by Evolve Funds Group Inc. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across health care sectors. The fund uses derivatives such as options to create its portfolio.
Evolve Global Healthcare Enhanced Yield Fund Fundamentals Summary
LIFE.B fundamental statistics | |
---|---|
Market cap | CA$190.62m |
Earnings (TTM) | CA$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs LIFE.B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LIFE.B income statement (TTM) | |
---|---|
Revenue | CA$0 |
Cost of Revenue | CA$0 |
Gross Profit | CA$0 |
Other Expenses | CA$0 |
Earnings | CA$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did LIFE.B perform over the long term?
See historical performance and comparison